Sareum Holdings (GB:SAR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sareum Holdings PLC, a biotech firm focused on developing kinase inhibitors for autoimmune diseases and cancer, has announced its Annual General Meeting to be held on December 19, 2024, in London. The company, which trades under the ticker SAR on the AIM market, will also provide online access to the AGM for shareholders via the Investor Meet Company platform. Sareum’s leading candidate, SDC-1801, has completed Phase 1 clinical development, showcasing potential in treating autoimmune diseases.
For further insights into GB:SAR stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Google Urges Appeals Court to Overturn App Store Change Ruling
- Symbotic Craters 36% on Financial Misstatements and 10-K Filing Delay
- How Will Apple Be Affected by Google/DOJ Battle? Barclays Chimes In
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
